STUDY OF SKIN CHANGES, HAND ABNORMALITIES AND PULMONARY MANIFESTATIONS IN DIFFUSE SCLERODERMA IN A TERTIARY CARE HOSPITAL OF EASTERN INDIA
-
Published:2022-11-01
Issue:
Volume:
Page:8-10
-
ISSN:
-
Container-title:INDIAN JOURNAL OF APPLIED RESEARCH
-
language:en
-
Short-container-title:IJAR
Author:
Naskar Biswajit1, Sarkar Liton2, Saha Bikram3, Bandyopadhyay Ramtanu4, Sarkar R N5
Affiliation:
1. MD(Medicine), Assistant Professor, Dept of Medicine, ESIC Medical College, Bihata, Patna, Bihar.Ex-Resident,Dept of Medicine, Medical College Kolkata. 2. MD(Medicine), Assistant Professor, Dept of Medicine, Jalpaiguri Govt Medical College West Bengal 3. Associate Professor.Dept of Medicine, Malda Medical College, WB. 4. Professor, Dept of Medicine R G Kar Medical College, Kolkata. 5. Ex-Prof & HOD, Dept of Medicine, Medical College Kolkata.
Abstract
Introduction: Scleroderma is a connective tissue disease characterized by brosis affecting the skin and internal
organs.Joint involvement has been reported to occur in 46%- 97% of SSc patients. Bone and soft tissues may also be
targeted; calcinosis and acro-osteolysis are thought to be the main characteristic ndings in SSc. Pulmonary disease in SSc falls into two major
categories: interstitial lung disease (ILD) and pulmonary hypertension. Using PFTs, signicant pulmonary involvement is detectable in 25% of
the patients with SSc within 3 years of initial diagnosis. The gold standard for determination of PAH in patients with SSc is right heart
catheterization. The HRCT features of lung disease are ground-glass opacication predominant or admixed with reticular abnormalities in the
majority of cases and little or no honeycombing. To study the demographic prole, Clini Aims and Objectives: cal Manifestations, Radiological
abnormalities, Lung involvement and PAH. 35 newly diagnosed Sclederma patients Materials and Methods: attending Medicine and
Rheumatology OPD of Medical College Kolkata were studied in this Cross-sectional observational study. Clinical Manifestations are noted and
Radiological Investigations were recorded in structured Proforma. Data analysed using standard statistical methods. In Results and Analysis:
our study, the study population had an F: M ratio of 10:1. majority of population (38%) having age group(30-40) yrs followed by less than 30 yrs
& 41yrs or more (31% each). In our study clinically hand abnormality was evident in 69% patients & radiologically hand abnormality was
evident in 74% patients. In our study population 29% patients have had acroosteolysis, 26% patients had erosion & 19% patients had exion
contracture. In our study we found all the patient with documented ILD had abnormal PFT. In our study group restrictive pattern in PFT was
evident in 63% patients & mixed pattern was evident in 23% patients. Twelve patients (35% of the total cohort) had pulmonary hypertension
dened as PAs of 30 mm Hg or greater. In our study we found Out of 30 patients with documented ILD in HRCT 20 patients had PAH & 10
patients had no PAH. Females are more affected than males. Majority Conclusion: of the patients affected are in the age group of 30-40
years.69% patients had clinically evident hand abnormality and 74% patients had radiologically evident hand abnormality.CXR showed ILD in
63% patients whereas86% patients had documented ILD in HRCT.Restrictive pattern of PFT abnormality is more than mixed pattern.57%
patients had documented PAH in echocardiography.HRCT is more sensitive than chest radiography for detection of ILD.
Publisher
World Wide Journals
Subject
General Economics, Econometrics and Finance,General Social Sciences,Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health,Multidisciplinary,General Chemical Engineering,Law,Surfaces, Coatings and Films,General Energy,Mechanical Engineering,Industrial and Manufacturing Engineering,Strategy and Management,Computer Science Applications,Industrial relations,Management Information Systems,Marketing,General Engineering,Developmental and Educational Psychology,Education,Engineering (miscellaneous),Instrumentation
Reference13 articles.
1. Clements PJ, Meedsger TA Jr, Feghali CA. Cutaneous involvement in systemic sclerosis. In: Clements PJ, Furst DE, eds. Systemic sclerosis, 2nd edition. Lippincott Williams and Wilkins, 2004;129–50. 2. Baron M, Lee P, Keystone EC.The articular manifestations of progressive systemic sclerosis (scleroderma). Ann Rheum Dis 1982;41:147–52. 3. Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972–2002. Ann Rheum Dis 2007;66:940–4. 4. Steen VD, Graham G, Conte C, Owens G, Medsger TA Jr. Isolated diffusing capacity reduction in systemic sclerosis. Arthritis Rheum 1992;35:765–70. 5. Denton CP, Humbert M, Rubin L, Black CM. Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions. Ann Rheum Dis 2006; 65:1336–40.
|
|